Article title: Getting the levothyroxine (LT4) dose right for adults with hypothyroidism: opportunities and challenges in the use of modern LT4 preparations
Authors: Gottwald-Hostalek, U. & Razvi, S.
Journal: Current Medical Research and Opinion
DOI: https://doi.org/10.1080/03007995.2022.2071059
When the above mentioned article was first published online, the value (68 µg) mentioned in the sentence “It is important to note here that the current tight regulatory requirements for manufacturing LT4 tablets means that even relatively small increments in tablet strength, for example from 25 mg to 38 mg or from 50 µg to 68 µg, are….” (section ‘Available tablet strengths and precision of LT4 dosing’) was incorrect. This is now corrected as ‘63 µg’ and re-published the article online.